Universitätsklinikum Carl Gustav Carus Dresden

Hospital


Location: Dresden, Germany (DE) DE

ISNI: 0000000110912917

ROR: https://ror.org/04za5zm41

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Germline variants of homology-directed repair or mismatch repair genes in cervical cancer () Kokemüller L, Ramachandran D, Schürmann P, Geffers R, Jentschke M, Böhmer G, Strauß HG, et al. Journal article Multimodal histopathologic models stratify hormone receptor-positive early breast cancer (2025) Boehm KM, El Nahhas OS, Marra A, Waters M, Jee J, Braunstein L, Schultz N, et al. Journal article Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patients (2025) Rautenberg C, Middeke JM, Röllig C, Stelljes M, Gaidzik V, Kriege O, Verbeek M, et al. Journal article Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor (2025) Wegert J, Appenzeller S, Treger TD, Streitenberger H, Ziegler B, Bausenwein S, Vokuhl C, et al. Journal article Course of mental distress among psychotherapists throughout two years of the COVID- 19 pandemic: individual and inter-relational resources make a difference—cross-sectional and longitudinal results of the VOICE study (2025) Mogwitz S, Wintermann GB, Albus C, Baranowski AM, Beschoner P, Erim Y, Geiser F, et al. Journal article Cluster analyses of contemporary embalming protocols in central European anatomy institutions: A collaborative effort to minimize chemical exposure (2025) Mohebimoushaei S, Antipova V, Biedermann U, Brand-Saberi B, Bräuer L, Caspers S, Doll S, et al. Journal article Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study (2025) Decker T, Brucker C, Engel A, Fasching P, Göhler T, Jackisch C, Janssen J, et al. Journal article Concept of Modeling Pharmacist-Led Medication Reviews in Clinical Setting: A Knowledge Graph-Based Approach (2025) Kiesel J, Karsten-Dafonte K, Farker K, Köck J, Kessler C, Strobach D, Fischer AH, et al. Book chapter / Article in edited volumes First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG (2025) Reinhard S, Utikal JS, Zaremba A, Lodde G, von Wasielewski I, Klespe KC, Meier F, et al. Journal article Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study (2025) Fasching P, Schmatloch S, Hauke J, Rey J, Jackisch C, Klare P, Link T, et al. Journal article